Several studies have implicated CCR5 variation and expression to be associated with COVID-19 severity (Gómez et al., 2020; Hubacek et al., 2021; Kasela et al., 2021), while others have not (Bernas et al., 2021). This evidence concerns the gene CCR5 and COVID-19.